Edition:
United States

NuVasive Inc (NUVA.OQ)

NUVA.OQ on NASDAQ Stock Exchange Global Select Market

76.78USD
23 Jun 2017
Change (% chg)

-- (--)
Prev Close
$76.78
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
210,568
52-wk High
$81.06
52-wk Low
$56.70

NUVA.OQ

Chart for NUVA.OQ

About

Nuvasive, Inc. is a medical device company. The Company focuses on developing minimally-disruptive surgical products and procedurally-integrated solutions for the spine surgery. Its product portfolio focuses on applications for spine fusion surgery, including biologics used to aid in the spinal fusion process. Its principal... (more)

Overall

Beta: 1.09
Market Cap(Mil.): $3,889.89
Shares Outstanding(Mil.): 50.66
Dividend: --
Yield (%): --

Financials

  NUVA.OQ Industry Sector
P/E (TTM): 78.85 34.18 19.01
EPS (TTM): 0.97 -- --
ROI: 3.73 13.01 -5.03
ROE: 7.96 15.52 -4.28

BRIEF-NuVasive announces FDA 510(K) clearance of Coroent small interbody system

* NuVasive - announced fda 510(K) clearance of coroent small interbody system indicated for intervertebral body fusion at contiguous levels in cervical spine Source text for Eikon: Further company coverage:

Mar 29 2017

Bets on financials, pharma power U.S. hedge funds' strong start to year

NEW YORK Several big-name U.S. hedge fund investors in the fourth quarter moved significant parts of their portfolios into financial and pharmaceutical stocks that are expected to benefit under the Trump administration, helping to power the sector to its best January performance in four years.

Feb 14 2017

Bets on financials, pharma power U.S. hedge funds' strong start to year

NEW YORK, Feb 14 Several big-name U.S. hedge fund investors in the fourth quarter moved significant parts of their portfolios into financial and pharmaceutical stocks that are expected to benefit under the Trump administration, helping to power the sector to its best January performance in four years.

Feb 14 2017

BRIEF-Nuvasive sees FY 2017 revenue $1.065 bln

* Nuvasive inc - preliminary full year 2016 non-gaap operating profit margin expected to be in line with guidance of 16.0%

Jan 09 2017

More From Around the Web

Earnings vs. Estimates